(ARRY) Array Biopharma complete technical analysis [charts+indicators] | Buy/Sell Array Biopharma | (ARRY) share price targets
Complete technical analysis of Array Biopharma (ARRY) by charts plus indicators, forecast predictions and share price targets for Array Biopharma (ARRY)
Array Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-04 View latest technical analysis
10 day averaged volume of Array Biopharma is 5844470
| Date | Daily Closing Price | Open | High | Low | Volume |
| 04 Mon Nov 2024 | 7.51 | 6.88 | 7.73 | 6.87 | 2.166 times |
| 01 Fri Nov 2024 | 6.70 | 6.64 | 6.80 | 6.51 | 0.851 times |
| 31 Thu Oct 2024 | 6.53 | 6.35 | 6.76 | 6.26 | 1.654 times |
| 30 Wed Oct 2024 | 6.22 | 6.38 | 6.63 | 6.21 | 1.073 times |
| 29 Tue Oct 2024 | 6.48 | 6.54 | 6.65 | 6.43 | 0.579 times |
| 28 Mon Oct 2024 | 6.67 | 6.55 | 6.92 | 6.43 | 1.059 times |
| 25 Fri Oct 2024 | 6.44 | 6.23 | 6.60 | 6.15 | 1.42 times |
| 24 Thu Oct 2024 | 6.17 | 6.26 | 6.38 | 6.01 | 0.921 times |
| 23 Wed Oct 2024 | 6.25 | 6.50 | 6.55 | 6.15 | 0.841 times |
| 22 Tue Oct 2024 | 6.58 | 6.73 | 6.76 | 6.55 | 0.657 times |
Stock of Array Biopharma (ARRY) has showed a significant upmove. This could be a good time to enter in this stock!
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 7.4, for a target of 7 or 6.67
Share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Target | 5.56 |
| Downside Target | 6.01 |
| Downside Target | 6.21 |
| Downside Target | 6.51 |
| Downside Target | 6.84 |
| Downside Target | 7.19 |
| Downside Target | 7.25 |
| Downside Target | 7.47 |
| Upside Target | 7.73 |
| Upside Target | 9.34 |
| Upside Target | 10.79 |
| Upside Target | 12.06 |
Intraday share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Intraday Target | 7.01 |
| Downside Intraday Target | 6.51 |
| Upside Intraday Target | 7.87 |
| Upside Intraday Target | 8.23 |
| Downside Intraday Target | 7.37 |
Weekly technical analysis of Array Biopharma (ARRY)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 04 Mon Nov 2024 | 7.51 | 6.88 | 7.73 | 6.87 | 0.415 times |
| 01 Fri Nov 2024 | 6.70 | 6.55 | 6.92 | 6.21 | 1.09 times |
| 25 Fri Oct 2024 | 6.44 | 6.80 | 6.84 | 6.01 | 1.268 times |
| 18 Fri Oct 2024 | 6.81 | 7.10 | 7.25 | 6.60 | 0.823 times |
| 11 Fri Oct 2024 | 7.16 | 6.46 | 7.19 | 6.23 | 1.305 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Array Biopharma (ARRY)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 04 Mon Nov 2024 | 7.51 | 6.64 | 7.73 | 6.51 | 0.147 times |
| 31 Thu Oct 2024 | 6.53 | 6.60 | 7.25 | 6.01 | 1.08 times |
| 30 Mon Sep 2024 | 6.60 | 6.66 | 7.47 | 5.56 | 0.7 times |
| 30 Fri Aug 2024 | 6.71 | 10.50 | 10.79 | 6.25 | 1.404 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Array Biopharma (ARRY)
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.65 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.65 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.